Cronos Group (CRON) Competitors C$2.63 -0.06 (-2.23%) As of 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesBuy This Stock CRON vs. AUP, BHC, CARA, SLS, TEV, ABT, NOT, PYR, NVO, and DNAShould you be buying Cronos Group stock or one of its competitors? The main competitors of Cronos Group include Aurinia Pharmaceuticals (AUP), Bausch Health Companies (BHC), Cara Operations (CARA), Solaris Resources (SLS), Tervita (TEV), Absolute Software Co. (ABT.TO) (ABT), Noront Resources (NOT), PyroGenesis Canada Inc. (PYR.V) (PYR), Novo Resources Corp. (NVO.V) (NVO), and Dalradian Resources (DNA). These companies are all part of the "pharmaceutical products" industry. Cronos Group vs. Its Competitors Aurinia Pharmaceuticals Bausch Health Companies Cara Operations Solaris Resources Tervita Absolute Software Co. (ABT.TO) Noront Resources PyroGenesis Canada Inc. (PYR.V) Novo Resources Corp. (NVO.V) Dalradian Resources Aurinia Pharmaceuticals (TSE:AUP) and Cronos Group (TSE:CRON) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, institutional ownership, profitability, media sentiment, risk, valuation, community ranking and earnings. Do institutionals & insiders have more ownership in AUP or CRON? 16.0% of Cronos Group shares are held by institutional investors. 46.4% of Cronos Group shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Which has better valuation and earnings, AUP or CRON? Cronos Group has higher revenue and earnings than Aurinia Pharmaceuticals. Cronos Group is trading at a lower price-to-earnings ratio than Aurinia Pharmaceuticals, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAurinia PharmaceuticalsC$57.59M0.00-C$190.03M-C$1.48N/ACronos GroupC$76.86M9.04-C$32.78M-C$0.18-14.63 Does the MarketBeat Community favor AUP or CRON? Aurinia Pharmaceuticals received 178 more outperform votes than Cronos Group when rated by MarketBeat users. Likewise, 72.22% of users gave Aurinia Pharmaceuticals an outperform vote while only 50.74% of users gave Cronos Group an outperform vote. CompanyUnderperformOutperformAurinia PharmaceuticalsOutperform Votes24772.22% Underperform Votes9527.78% Cronos GroupOutperform Votes6950.74% Underperform Votes6749.26% Does the media prefer AUP or CRON? In the previous week, Cronos Group had 1 more articles in the media than Aurinia Pharmaceuticals. MarketBeat recorded 1 mentions for Cronos Group and 0 mentions for Aurinia Pharmaceuticals. Aurinia Pharmaceuticals' average media sentiment score of 0.00 equaled Cronos Group'saverage media sentiment score. Company Overall Sentiment Aurinia Pharmaceuticals Neutral Cronos Group Neutral Is AUP or CRON more profitable? Aurinia Pharmaceuticals has a net margin of 0.00% compared to Cronos Group's net margin of -42.65%. Aurinia Pharmaceuticals' return on equity of 0.00% beat Cronos Group's return on equity.Company Net Margins Return on Equity Return on Assets Aurinia PharmaceuticalsN/A N/A N/A Cronos Group -42.65%-4.40%-3.73% SummaryAurinia Pharmaceuticals and Cronos Group tied by winning 6 of the 12 factors compared between the two stocks. Get Cronos Group News Delivered to You Automatically Sign up to receive the latest news and ratings for CRON and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CRON and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CRON vs. The Competition Export to ExcelMetricCronos GroupDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$694.49MC$2.19BC$5.58BC$6.07BDividend YieldN/A2.92%5.28%6.72%P/E Ratio-14.634.1027.1936.73Price / Sales9.04667.18408.781,028.25Price / Cash1.6710.2538.3283.29Price / Book0.897.236.974.20Net Income-C$32.78MC$20.70BC$3.23BC$301.20M7 Day Performance-3.31%1.62%-0.88%1.27%1 Month Performance-7.07%5.65%7.81%5.44%1 Year Performance-22.42%107.99%31.53%24.30% Cronos Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CRONCronos GroupN/AC$2.63-2.2%N/A-22.0%C$694.49MC$76.86M-14.63450AUPAurinia PharmaceuticalsN/AN/AN/AN/AC$2.15BC$57.59M-11.32300High Trading VolumeBHCBausch Health CompaniesN/AC$6.29+2.3%N/A-13.4%C$1.64BC$6.69B-9.2019,900Gap UpCARACara OperationsN/AN/AN/AN/AC$1.62BN/A0.0080SLSSolaris Resources1.2288 of 5 starsC$6.14+3.5%C$13.90+126.4%+31.9%C$704.35MN/A-10.7010TEVTervitaN/AN/AN/AN/AC$672.00MC$1.36B-645.5636,800Gap UpABTAbsolute Software Co. (ABT.TO)N/AN/AN/AN/AC$636.46MC$104.67M63.42115,000High Trading VolumeNOTNoront ResourcesN/AC$1.10-0.5%N/A+0.0%C$612.18MN/A-7.20101,700PYRPyroGenesis Canada Inc. (PYR.V)N/AC$3.85+11.0%N/A+0.0%C$606.96MC$6.01M-154.0090Gap UpNVONovo Resources Corp. (NVO.V)N/AC$2.38-0.4%N/A+0.0%C$548.24MN/A-21.2554,400DNADalradian ResourcesN/AN/AN/AN/AC$519.02MN/A-56.15640 Related Companies and Tools Related Companies Aurinia Pharmaceuticals Alternatives Bausch Health Companies Alternatives Cara Operations Alternatives Solaris Resources Alternatives Tervita Alternatives Absolute Software Co. (ABT.TO) Alternatives Noront Resources Alternatives PyroGenesis Canada Inc. (PYR.V) Alternatives Novo Resources Corp. (NVO.V) Alternatives Dalradian Resources Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (TSE:CRON) was last updated on 6/13/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | SponsoredWhy July 22nd Could Mean Big Changes for Social SecurityIn a stunning move, President Trump has authorized an AI-led transformation of federal agencies, including Soc...Altimetry | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cronos Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.